+987.9%
MRNA vs FIVN
+55.4%
+932.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FIVN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.6% | +11.5% | +12.8% |
| 7D | +20.6% | -3.4% | +24.0% | +21.4% |
| 30D | +27.1% | +5.8% | +21.4% | +26.0% |
| 3M | +353.4% | +22.0% | +331.4% | +340.9% |
| 6M | +446.3% | +55.7% | +390.5% | +423.6% |
| YTD | +776.2% | +81.3% | +694.9% | +722.6% |
| 1Y | +987.9% | +58.0% | +929.9% | +954.0% |
| All | +987.9% | +55.4% | +932.5% | +954.0% |
Cumulative growth
Daily Returns
Daily percentage return beside FIVN.
Daily Out/Under-Performance
Portfolio return minus FIVN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FIVN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FIVN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling